Posted on March 18, 2018 by #LCSM Chat
#LCSM Chat Topic 3/22: Slicing the Pie–How Can Lung Cancer Patient Groups, Clinicians, and Researchers Best Work Together?
Lung cancer management has shifted from a broadly defined process to one increasingly recognized as narrow subgroups that have distinct patterns of cancer biology and optimal treatments. The first patient group to splinter into a separate branch of management was the approximately 10% of people with EGFR mutation-positive NSCLC, and the treatment options for them continue to become deeper and more complex as we gain more active agents and struggle with enviable problems like the best sequencing and protection of the brain against metastatic spread. Other “driver mutations” such as ALK and… Read More
Posted on November 27, 2017 by Gray Connections
We end lung cancer awareness month with a very interesting topic. The next #LCSM Tweet Chat on Thursday, November 30th at 5 PM Pacific/ 8 PM Eastern will discuss “Expanding the web of knowledge in #lungcancer.” The moderator for this chat is Dr. David Tom Cooke (@DavidCookeMD). There is a vast amount of information on the optimal treatments and approaches to beat lung cancer. Whether it is lung cancer screening, surgery for early stage disease, SBRT for patients with early stage disease who are not candidates for surgery, the importance of molecular… Read More
Posted on October 4, 2017 by #LCSM Chat
With November Lung Cancer Awareness Month #LCAM17 just around the corner, this is a good time to explore the many ways we can do advocacy work, whether for ourselves or on behalf of a loved one. In fact, this is the topic of this Thursday’s edition of #LCSM Chat at 5 pm Pacific, 8 pm Eastern, moderated by Deana Hendrickson. So, let’s roll up our sleeves and get to it. Topic Questions T1: Are there particular advocacy groups with whom you like to work? Which ones? Why? T2: Have you ever done… Read More